Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 88901-88950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05235425
The Lifestyle Education About Prediabetes (Leap) Study
NAActive, not recruiting
300 participants
Started: Mar 20, 2022 · Completed: Nov 15, 2025
1 condition2 sponsors1 location
NCT05527990
TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters
N/ARecruiting
650 participants
Started: Mar 20, 2022 · Completed: Dec 31, 2023
1 condition3 sponsors2 locations
NCT05430620
Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
PHASE3Recruiting
60 participants
Started: Mar 20, 2022 · Completed: Jan 1, 2026
4 conditions1 sponsor1 location
NCT04987489
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
PHASE2Active, not recruiting
60 participants
Started: Mar 20, 2022 · Completed: Sep 3, 2025
2 conditions1 sponsor16 locations
NCT04566991
Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)
PHASE2Recruiting
120 participants
Started: Mar 20, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors2 locations
NCT05242276
Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study
N/ARecruiting
1,200 participants
Started: Mar 20, 2022 · Completed: Mar 20, 2026
1 condition1 sponsor1 location
NCT05158517
VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER)
N/AActive, not recruiting
349 participants
Started: Mar 20, 2022 · Completed: Mar 20, 2025
1 condition2 sponsors1 location
NCT06542029
Interventions for the Wellbeing of Students At the University of Helsinki
NARecruiting
600 participants
Started: Mar 20, 2022 · Completed: Jul 31, 2026
1 condition4 sponsors1 location
NCT06453304
Effectiveness of Glycyrrhizin as Intracanal Medication in Root Canal Disinfection and Inflammatory Cytokines
PHASE2/PHASE3Recruiting
36 participants
Started: Mar 20, 2022 · Completed: Jul 10, 2024
1 condition1 sponsor1 location
NCT05325710
Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
NARecruiting
230 participants
Started: Mar 20, 2022 · Completed: Apr 1, 2028
1 condition2 sponsors1 location
NCT04612738
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations
NARecruiting
1,500 participants
Started: Mar 19, 2022 · Completed: Jan 31, 2026
5 conditions3 sponsors72 locations
NCT06746480
Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
PHASE2Recruiting
33 participants
Started: Mar 19, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06495463
Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan
NARecruiting
110 participants
Started: Mar 19, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05196789
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)
N/ARecruiting
350 participants
Started: Mar 18, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05187650
Effectiveness of a Powered Exoskeleton Combined with FES for Patients with Chronic SCI: a RCT
NARecruiting
34 participants
Started: Mar 18, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06707922
A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
NAEnrolling by invitation
350 participants
Started: Mar 18, 2022 · Completed: Jul 31, 2029
1 condition2 sponsors30 locations
NCT04993313
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study
NAActive, not recruiting
62 participants
Started: Mar 18, 2022 · Completed: Feb 28, 2026
17 conditions2 sponsors1 location
NCT05336526
Evaluation of the Safety and Performance of SYMATESE AESTHETICS ESTYME® MATRIX Round Microtextured Silicone Gel-Filled Breast Implants in the Breast Augmentation
NAActive, not recruiting
88 participants
Started: Mar 18, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor6 locations
NCT05592665
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
NAActive, not recruiting
42 participants
Started: Mar 18, 2022 · Completed: Jan 16, 2031
1 condition2 sponsors1 location
NCT05245006
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
PHASE1Recruiting
37 participants
Started: Mar 18, 2022 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT05876533
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
N/AActive, not recruiting
216 participants
Started: Mar 18, 2022 · Completed: Mar 15, 2025
1 condition1 sponsor8 locations
NCT05346016
The PEARL-AGE Study. Multigenerational Gut Bacteria Transmission and Its Stability in Families.
N/AEnrolling by invitation
600 participants
Started: Mar 18, 2022 · Completed: Mar 31, 2026
1 condition4 sponsors1 location
NCT04577755
Pomalidomide Treatment in Patients With Kaposi Sarcoma
PHASE2Active, not recruiting
45 participants
Started: Mar 18, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor15 locations
NCT04938765
Effect of Magnesium Sulfate Bolus on Intraoperative Neuromonitoring
PHASE4Recruiting
50 participants
Started: Mar 18, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05057611
Hemodynamic Phenotype and Capillary Refill Time-targeted Resuscitation Strategy
NARecruiting
1,500 participants
Started: Mar 18, 2022 · Completed: Jun 30, 2025
1 condition4 sponsors1 location
NCT05375461
TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail
PHASE3Active, not recruiting
287 participants
Started: Mar 18, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05009069
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
PHASE2Active, not recruiting
58 participants
Started: Mar 18, 2022 · Completed: Nov 6, 2026
2 conditions1 sponsor5 locations
NCT05032976
Korea Comirnaty Post-marketing Surveillance
N/AActive, not recruiting
12,000 participants
Started: Mar 18, 2022 · Completed: Mar 4, 2027
5 conditions1 sponsor1 location
NCT05300256
Peripheral Heating and Glucose Tolerance
NARecruiting
30 participants
Started: Mar 18, 2022 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT05079711
Comparative Performance of a Vaginal Yeast Test
N/ARecruiting
1,200 participants
Started: Mar 18, 2022 · Completed: Aug 30, 2026
1 condition2 sponsors3 locations
NCT05207059
Healthy Early Life Moments in Singapore
NARecruiting
500 participants
Started: Mar 18, 2022 · Completed: Dec 31, 2028
4 conditions2 sponsors1 location
NCT04950868
The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
PHASE1Active, not recruiting
22 participants
Started: Mar 18, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT04804241
Senicapoc in Alzheimer's Disease
PHASE2Recruiting
55 participants
Started: Mar 18, 2022 · Completed: Jun 30, 2026
2 conditions4 sponsors2 locations
NCT05350787
Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With R/R B-ALL
PHASE1Recruiting
16 participants
Started: Mar 18, 2022 · Completed: Aug 30, 2025
1 condition1 sponsor2 locations
NCT07055763
Effect Of Nigella Sativa Oil for the Treatment of Hypertension
NAActive, not recruiting
60 participants
Started: Mar 17, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05844384
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
NARecruiting
30 participants
Started: Mar 17, 2022 · Completed: Mar 17, 2024
2 conditions2 sponsors1 location
NCT05131607
21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial
NAActive, not recruiting
45 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2024
1 condition2 sponsors1 location
NCT05273320
Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities
PHASE1Recruiting
30 participants
Started: Mar 17, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05169632
Computerized Cognitive Rehabilitation of Executive Deficits in Stroke Patients
NARecruiting
32 participants
Started: Mar 17, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT05223491
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
NARecruiting
220 participants
Started: Mar 17, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors8 locations
NCT05078034
HNFO With or Without Helmet NIV for Oxygenation Support in Acute Respiratory Failure Pilot RCT
NARecruiting
200 participants
Started: Mar 17, 2022 · Completed: Feb 1, 2025
1 condition1 sponsor11 locations
NCT05279560
Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation
NAActive, not recruiting
114 participants
Started: Mar 17, 2022 · Completed: Jun 30, 2030
4 conditions1 sponsor1 location
NCT05425992
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
N/ARecruiting
20 participants
Started: Mar 17, 2022 · Completed: Nov 4, 2025
2 conditions2 sponsors1 location
NCT05219721
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
PHASE1Recruiting
18 participants
Started: Mar 17, 2022 · Completed: Oct 1, 2025
2 conditions2 sponsors1 location
NCT05295264
Active Pregnancy. Mental and Emotional Health Care to Pregnant Woman During and After Coronavirus (COVID-19)
NARecruiting
500 participants
Started: Mar 17, 2022 · Completed: Dec 30, 2025
2 conditions7 sponsors1 location
NCT04804553
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
PHASE3Recruiting
60 participants
Started: Mar 17, 2022 · Completed: Dec 29, 2028
1 condition1 sponsor43 locations
NCT04691622
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
PHASE1Recruiting
48 participants
Started: Mar 17, 2022 · Completed: Oct 30, 2028
3 conditions1 sponsor3 locations
NCT05120570
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2028
4 conditions1 sponsor1 location
NCT05313321
Survival of the Insignia Stem in Total Hip Arthroplasty
N/AActive, not recruiting
100 participants
Started: Mar 17, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04875754
A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Mar 17, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations